Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative

William E. Klunk, Brian J. Bacskai, Chester A. Mathis, Stephen T. Kajdasz, Megan E. McLellan, Matthew P. Frosch, Manik L. Debnath, Daniel Holt, Yanming Wang, Bradley T. Hyman

Research output: Contribution to journalArticle

Abstract

The identification of amyloid deposits in living Alzheimer disease (AD) patients is important for both early diagnosis and for monitoring the efficacy of newly developed anti-amyloid therapies. Methoxy-X04 is a derivative of Congo red and Chrysamine-G that contains no acid groups and is therefore smaller and much more lipophilic than Congo red or Chrysamine-G. Methoxy-X04 retains in vitro binding affinity for amyloid β (Aβ) fibrils (Ki = 26.8 nM) very similar to that of Chrysamine-G (Ki = 25.3 nM). Methoxy-X04 is fluorescent and stains plaques, tangles, and cerebrovascular amyloid in postmortem sections of AD brain with good specificity. Using multiphoton microscopy to obtain high-resolution (1 μm) fluorescent images from the brains of living PS1/APP mice, individual plaques could be distinguished within 30 to 60 min after a single i.v. injection of 5 to 10 mg/kg methoxy-X04. A single i.p. injection of 10 mg/kg methoxy-X04 also produced high contrast images of plaques and cerebrovascular amyloid in PS1/APP mouse brain. Complementary quantitative studies using tracer doses of carbon-11-labeled methoxy-X04 show that it enters rat brain in amounts that suggest it is a viable candidate as a positron emission tomography (PET) amyloid-imaging agent for in vivo human studies.

Original languageEnglish (US)
Pages (from-to)797-805
Number of pages9
JournalJournal of Neuropathology and Experimental Neurology
Volume61
Issue number9
StatePublished - Sep 2002
Externally publishedYes

Fingerprint

Congo Red
Transgenic Mice
Microscopy
Amyloid
Amyloid Plaques
Brain
Alzheimer Disease
Injections
Positron-Emission Tomography
1,4-bis(4'-hydroxystyryl)-2-methoxybenzene
Early Diagnosis
Coloring Agents
Carbon
Acids
chrysamine G

Keywords

  • Alzheimer disease
  • Amyloid
  • Chrysamine-G
  • Imaging
  • Multiphoton microscopy
  • Positron emission tomography
  • Transgenic mice

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Klunk, W. E., Bacskai, B. J., Mathis, C. A., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., ... Hyman, B. T. (2002). Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. Journal of Neuropathology and Experimental Neurology, 61(9), 797-805.

Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. / Klunk, William E.; Bacskai, Brian J.; Mathis, Chester A.; Kajdasz, Stephen T.; McLellan, Megan E.; Frosch, Matthew P.; Debnath, Manik L.; Holt, Daniel; Wang, Yanming; Hyman, Bradley T.

In: Journal of Neuropathology and Experimental Neurology, Vol. 61, No. 9, 09.2002, p. 797-805.

Research output: Contribution to journalArticle

Klunk, WE, Bacskai, BJ, Mathis, CA, Kajdasz, ST, McLellan, ME, Frosch, MP, Debnath, ML, Holt, D, Wang, Y & Hyman, BT 2002, 'Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative', Journal of Neuropathology and Experimental Neurology, vol. 61, no. 9, pp. 797-805.
Klunk, William E. ; Bacskai, Brian J. ; Mathis, Chester A. ; Kajdasz, Stephen T. ; McLellan, Megan E. ; Frosch, Matthew P. ; Debnath, Manik L. ; Holt, Daniel ; Wang, Yanming ; Hyman, Bradley T. / Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. In: Journal of Neuropathology and Experimental Neurology. 2002 ; Vol. 61, No. 9. pp. 797-805.
@article{b1d16dcf69304503a58eabfc865a0d1f,
title = "Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative",
abstract = "The identification of amyloid deposits in living Alzheimer disease (AD) patients is important for both early diagnosis and for monitoring the efficacy of newly developed anti-amyloid therapies. Methoxy-X04 is a derivative of Congo red and Chrysamine-G that contains no acid groups and is therefore smaller and much more lipophilic than Congo red or Chrysamine-G. Methoxy-X04 retains in vitro binding affinity for amyloid β (Aβ) fibrils (Ki = 26.8 nM) very similar to that of Chrysamine-G (Ki = 25.3 nM). Methoxy-X04 is fluorescent and stains plaques, tangles, and cerebrovascular amyloid in postmortem sections of AD brain with good specificity. Using multiphoton microscopy to obtain high-resolution (1 μm) fluorescent images from the brains of living PS1/APP mice, individual plaques could be distinguished within 30 to 60 min after a single i.v. injection of 5 to 10 mg/kg methoxy-X04. A single i.p. injection of 10 mg/kg methoxy-X04 also produced high contrast images of plaques and cerebrovascular amyloid in PS1/APP mouse brain. Complementary quantitative studies using tracer doses of carbon-11-labeled methoxy-X04 show that it enters rat brain in amounts that suggest it is a viable candidate as a positron emission tomography (PET) amyloid-imaging agent for in vivo human studies.",
keywords = "Alzheimer disease, Amyloid, Chrysamine-G, Imaging, Multiphoton microscopy, Positron emission tomography, Transgenic mice",
author = "Klunk, {William E.} and Bacskai, {Brian J.} and Mathis, {Chester A.} and Kajdasz, {Stephen T.} and McLellan, {Megan E.} and Frosch, {Matthew P.} and Debnath, {Manik L.} and Daniel Holt and Yanming Wang and Hyman, {Bradley T.}",
year = "2002",
month = "9",
language = "English (US)",
volume = "61",
pages = "797--805",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Imaging Aβ plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative

AU - Klunk, William E.

AU - Bacskai, Brian J.

AU - Mathis, Chester A.

AU - Kajdasz, Stephen T.

AU - McLellan, Megan E.

AU - Frosch, Matthew P.

AU - Debnath, Manik L.

AU - Holt, Daniel

AU - Wang, Yanming

AU - Hyman, Bradley T.

PY - 2002/9

Y1 - 2002/9

N2 - The identification of amyloid deposits in living Alzheimer disease (AD) patients is important for both early diagnosis and for monitoring the efficacy of newly developed anti-amyloid therapies. Methoxy-X04 is a derivative of Congo red and Chrysamine-G that contains no acid groups and is therefore smaller and much more lipophilic than Congo red or Chrysamine-G. Methoxy-X04 retains in vitro binding affinity for amyloid β (Aβ) fibrils (Ki = 26.8 nM) very similar to that of Chrysamine-G (Ki = 25.3 nM). Methoxy-X04 is fluorescent and stains plaques, tangles, and cerebrovascular amyloid in postmortem sections of AD brain with good specificity. Using multiphoton microscopy to obtain high-resolution (1 μm) fluorescent images from the brains of living PS1/APP mice, individual plaques could be distinguished within 30 to 60 min after a single i.v. injection of 5 to 10 mg/kg methoxy-X04. A single i.p. injection of 10 mg/kg methoxy-X04 also produced high contrast images of plaques and cerebrovascular amyloid in PS1/APP mouse brain. Complementary quantitative studies using tracer doses of carbon-11-labeled methoxy-X04 show that it enters rat brain in amounts that suggest it is a viable candidate as a positron emission tomography (PET) amyloid-imaging agent for in vivo human studies.

AB - The identification of amyloid deposits in living Alzheimer disease (AD) patients is important for both early diagnosis and for monitoring the efficacy of newly developed anti-amyloid therapies. Methoxy-X04 is a derivative of Congo red and Chrysamine-G that contains no acid groups and is therefore smaller and much more lipophilic than Congo red or Chrysamine-G. Methoxy-X04 retains in vitro binding affinity for amyloid β (Aβ) fibrils (Ki = 26.8 nM) very similar to that of Chrysamine-G (Ki = 25.3 nM). Methoxy-X04 is fluorescent and stains plaques, tangles, and cerebrovascular amyloid in postmortem sections of AD brain with good specificity. Using multiphoton microscopy to obtain high-resolution (1 μm) fluorescent images from the brains of living PS1/APP mice, individual plaques could be distinguished within 30 to 60 min after a single i.v. injection of 5 to 10 mg/kg methoxy-X04. A single i.p. injection of 10 mg/kg methoxy-X04 also produced high contrast images of plaques and cerebrovascular amyloid in PS1/APP mouse brain. Complementary quantitative studies using tracer doses of carbon-11-labeled methoxy-X04 show that it enters rat brain in amounts that suggest it is a viable candidate as a positron emission tomography (PET) amyloid-imaging agent for in vivo human studies.

KW - Alzheimer disease

KW - Amyloid

KW - Chrysamine-G

KW - Imaging

KW - Multiphoton microscopy

KW - Positron emission tomography

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0036707494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036707494&partnerID=8YFLogxK

M3 - Article

C2 - 12230326

AN - SCOPUS:0036707494

VL - 61

SP - 797

EP - 805

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 9

ER -